Amat, Flore <br/><br/>
Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?  [electronic resource] 

 -  Expert review of respiratory medicine  06 2018 
 - 475-482 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1747-6356 
<br/><br/><label>Standard No.: </label>10.1080/17476348.2018.1475233  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Asthmatic Agents--economics<br/>Asthma--drug therapy<br/>Biomarkers--metabolism<br/>Cell Adhesion Molecules--metabolism<br/>Cell Count<br/>Child<br/>Cost-Benefit Analysis<br/>Eosinophil Cationic Protein--metabolism<br/>Eosinophil-Derived Neurotoxin--metabolism<br/>Eosinophils--metabolism<br/>Exhalation<br/>Humans<br/>Inflammation--metabolism<br/>Nitric Oxide--metabolism<br/>Omalizumab--economics<br/>Phenotype<br/>Sputum--metabolism